Login / Signup

Mutant α-synuclein enhances firing frequencies in dopamine substantia nigra neurons by oxidative impairment of A-type potassium channels.

Mahalakshmi SubramaniamDaniel AlthofSuzana GispertJochen SchwenkGeorg AuburgerAkos KulikBernd FaklerJochen Roeper
Published in: The Journal of neuroscience : the official journal of the Society for Neuroscience (2015)
Parkinson disease (PD) is an α-synucleinopathy resulting in the preferential loss of highly vulnerable dopamine (DA) substantia nigra (SN) neurons. Mutations (e.g., A53T) in the α-synuclein gene (SNCA) are sufficient to cause PD, but the mechanism of their selective action on vulnerable DA SN neurons is unknown. In a mouse model overexpressing mutant α-synuclein (A53T-SNCA), we identified a SN-selective increase of in vivo firing frequencies in DA midbrain neurons, which was not observed in DA neurons in the ventral tegmental area. The selective and age-dependent gain-of-function phenotype of A53T-SCNA overexpressing DA SN neurons was in part mediated by an increase of their intrinsic pacemaker frequency caused by a redox-dependent impairment of A-type Kv4.3 potassium channels. This selective enhancement of "stressful pacemaking" of DA SN neurons in vivo defines a functional response to mutant α-synuclein that might be useful as a novel biomarker for the "DA system at risk" before the onset of neurodegeneration in PD.
Keyphrases
  • spinal cord
  • parkinson disease
  • mouse model
  • deep brain stimulation
  • spinal cord injury
  • metabolic syndrome
  • dna methylation
  • magnetic resonance
  • copy number
  • pulmonary embolism